Quantitative Systems Pharmacology Conference

Lunch, snacks, and coffee are provided.

With hundreds of FDA and EMA submissions supported by QSP models, QSP has finally come of age. The now-proven high return of investment from QSP has led to every major pharma company and a significant number of biotechs investing in QSP groups or partnering with QSP vendors. However, the vast majority of preclinical and clinical programs are still not supported by QSP. At this point, we see this not as a limitation of the value of QSP but as a challenge for implementing QSP at scale. This workshop will unveil Certara IQ™, an innovative QSP environment that enables the scaling of QSP from only supporting a small minority of projects to supporting the entire pipeline. We will focus on four key decision points in the drug development pipeline:

• New Target Feasibility
• Determining Best in Class Properties
• First In Human Dose Projection
• Recommended Phase 2 Dose

For each, we will demonstrate how to use Certara IQ to efficiently answer these questions with practical examples.

Attendees should bring their laptops for this hands-on workshop. Prior to the event, you will receive an email from us to create an account in preparation for the workshop.